2022 ASCO Annual Meeting: Improving Standard Care for Advanced Pancreatic Cancer and Older Adults with Mantle Cell Lymphoma
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Today’s studies explore adding nimotuzumab to chemotherapy to treat KRAS wild-type pancreatic cancer and adding ibrutinib to standard care for older adults with mantle cell lymphoma.